Early stage breast cancer with concomittant primary hyperparathyroidism and autoimmune thrombocytopenia: A case report

1Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Co-existence of early stage breast cancer, primary hyperparathyroidism and autoimmune thrombocytopenia has never been reported. While there is an increased prevalence of primary hyperparathyroidism in young patients with breast cancer, this is the first case report of early breast cancer with both primary hyperthyroidism and autoimmune thrombocytopenia.

References Powered by Scopus

Breast-cancer predisposition in multiple endocrine neoplasia type 1

97Citations
N/AReaders
Get full text

Paraneoplastic autoimmune thrombocytopenia in solid tumors

65Citations
N/AReaders
Get full text

Increased prevalence of primary hyperparathyroidism in treated breast cancer

37Citations
N/AReaders
Get full text

Cited by Powered by Scopus

The “janus face” of platelets in cancer

36Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Phakathi, B. P., Mannell, A., & Nietz, S. (2018). Early stage breast cancer with concomittant primary hyperparathyroidism and autoimmune thrombocytopenia: A case report. South African Journal of Surgery, 56(2), 64–65. https://doi.org/10.17159/2078-5151/2018/v56n1a2191

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 3

60%

Professor / Associate Prof. 2

40%

Readers' Discipline

Tooltip

Medicine and Dentistry 3

38%

Agricultural and Biological Sciences 2

25%

Biochemistry, Genetics and Molecular Bi... 2

25%

Nursing and Health Professions 1

13%

Save time finding and organizing research with Mendeley

Sign up for free